[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP0730656A1 - SYSTEME D'EXPRESSION A $i(ASPERGILLUS FOETIDUS) - Google Patents

SYSTEME D'EXPRESSION A $i(ASPERGILLUS FOETIDUS)

Info

Publication number
EP0730656A1
EP0730656A1 EP95903612A EP95903612A EP0730656A1 EP 0730656 A1 EP0730656 A1 EP 0730656A1 EP 95903612 A EP95903612 A EP 95903612A EP 95903612 A EP95903612 A EP 95903612A EP 0730656 A1 EP0730656 A1 EP 0730656A1
Authority
EP
European Patent Office
Prior art keywords
promoter
amylase
enzyme
host cell
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95903612A
Other languages
German (de)
English (en)
Inventor
Randy M. Berka
Wendy Yoder
Shinobu Takagi
Karuppan Chettier Boominathan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes Inc
Original Assignee
Novo Nordisk Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Biotech Inc filed Critical Novo Nordisk Biotech Inc
Publication of EP0730656A1 publication Critical patent/EP0730656A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi

Definitions

  • Aspergillus niger and Aspergillus oryzae have also been described as being useful in recombinant production of proteins.
  • other species of Aspergillus have not been shown to be useful in expression of heterologous protein, and in fact, because of poor expression, and/or excessive production of proteases or mycotoxins, not all species of Aspergillus are suitable as host cells for this purpose, nor is this ability predictable from one species to the next.
  • Aspergillus foetidus has been used for the expression of a hepatitis B antigen (Hongdi, et al.
  • the host cells and methods of the present invention are unexpectedly more efficient in the recombinant production of various fungal enzymes than are other known Aspergillus species, such as A. niger or A. oryzae.
  • the species Aspergillus foetidus belongs to the Nigri Section of the genus Aspergillus .
  • the members of the section Nigri as exemplified by Aspergillus niger, are characterized by radiate conidial heads and conidial masses in shades of black; globose vesicles; stipes which are smooth and hyaline, or pigmented below the vesicle; metulae present or absent, and often pigmented ("The Genus Aspergillus” , by K.B. Raper and D.I. Fennel, The Williams & Wikins Company, Baltimore, 1965) .
  • A. foetidus is generally characterized by sterigmata in two series; conidial heads persistently grayish dark brown or olive brown; conidia globose or nearly so at maturity, irregularly and finely roughened. More specifically, the species is characterized by colonies on Czapek's solution agar growing rather slowly at room temperature (24-26'C), attaining a diameter of 3.5 to 4.5 cm in 10 days to 2 weeks, with vegetative mycelium in white or yellowish shades, largely submerged or forming a rather compact and comparatively tough surface, plane or radially furrowed, azonate or weakly zonate, in some strains bearing abundant olive-brown to brownish black conidial heads throughout except at the growing margin, in others sporulating tardily and less abundantly; exudate lacking or inconspicuous; colony reverse in yellow to orange shades, becoming reddish brown in age odor very strong, penetrating, actinomycete- like.
  • ATCC American Type Culture Collection
  • NRRL Agricultural Research Service Culture Collection
  • FGSC Fungal Genetics Stock Center
  • DSM Deutsche Sammlung von Mikroorganismen und Zellkulturen
  • IAM Institute of Applied Microbiology
  • the promoter may be any DNA sequence that shows strong transcriptional activity in these species, and may be derived form genes encoding both extracellular and intracellular proteins, such as amylases, glucoamylases, proteases, lipases, cellulases and glycolytic enzymes. Such suitable promoters may be derived from genes for A. oryzae
  • glucoamylase or an amylase gene from an Aspergillus species, an amylase gene from a Bacillus species, a lipase or proteinase gene from Rhizomucor miehei , the gene for the ⁇ -factor from Saccharomyces cerevisiae, or the calf prochymosin gene.
  • the preregion is derived from the gene for A. oryzae TAKA amylase, A. niger neutral ⁇ -amylase, A. niger acid stable ⁇ -amylase, B. licheniformis ⁇ -amylase, the maltogenic amylase from Bacillus NCIB 11837, B.
  • the gene for the desired product functionally linked to promoter and terminator sequences may be incorporated in a vector containing the selection marker or may be placed on a separate vector or plasmid capable of being integrated into the genome of the host strain.
  • the vector system may be a single vector or plasmid or two or more vectors or plasmids which together contain the total DNA to be integrated into the genome.
  • Vectors or plasmids may be linear or closed circular molecules.
  • the host is transformed with two vectors, one including the selection marker and the other comprising the remaining heterologous DNA to be introduced, including promoter, the gene for the desired protein and transcription terminator and polyadenylation sequences.
  • the present host cell species can be used to express any prokaryotic or eukaryotic heterologous enzymes of interest, and is preferably used to express eukaryotic enzymes.
  • This species is particularly useful in that it has been approved for use in the food industry.
  • Of particular interest for this species is its use in expression of heterologous fungal enzymes (Regulatory Aspects of Microbial Food Enzymes, Third Edition, The Association of Microbial Food Enzyme Producers, Brussels, Belgium) .
  • the present host cells may also be used in recombinant production of proteins which are native to the host cells.
  • examples of such use include, but are not limited to, placing an A. foetidus native protein under the control of a different promoter to enhance expression of the protein, to expedite export of a native protein of interest outside the cell by use of a signal sequence, or to increase copy number of a protein which is normally produced by the subject host cells.
  • the present invention also encompasses such recombinant production of homologous proteins, to the extent that such expression involves the use of genetic elements not native to the host cell, or use of native elements which have been manipulated to function in a manner not normally seen in the host cell.
  • the casein plate clearing assay is conducted as follows.
  • the plate medium is composed of 20 g/1 skim milk, 20 g/1 agarose, and 0.2M citrate-phosphate buffer for tests run at pH 5 and pH 7, and glycine NaOH buffer for tests run at pH 9.
  • Milk powder is mixed with 100 ml of buffer and kept at 60 * C.
  • Agarose is mixed with 400 ml of buffer and autoclaved 5 minutes. After slight cooling, the warm milk mixture is added, and the mixture inverted gently 2-3 times to mix.
  • the medium is poured into 150 mm plates using 50-70 ml per plate and stored at 5'C until use.
  • the supernatants of each culture are also used to evaluate the strains' extracellular protein production.
  • Novex San Diego, California 8-16% gradient gels, prepared according to manufacturer's instructions, are used to assess the protein profile.
  • dissociation buffer 4 ml 1M Tris-HCl,pH 6.8, 1 g SDS, 617 mg dithio
  • the gels are silver stained according to the Biorad Silver Stain Plus Protocol (Biorad Laboratories, Hercules, CA) . Those isolates showing large numbers of bands are considered less suitable as potential new hosts, while those showing relatively clean profiles with only 1-4 major bands are considered for further testing.
  • the majority of suitable potential candidates are found among the members of the section Nigri. Based on these results, the following isolates are selected for transformation studies: A. foetidus E46, A . foetidus CBS 103.14, A. foetidus var. pallidus(NRRL 356), A. foetidus N0953 (NRRL 337; ATCC 10254) A. japonicus A1438 (CBS 568.65), A. aculeatus N1136 (CBS
  • the vectors pJaL77 and pJaLl54 are used in transformation of host cells with the hygromycin B resistance selectable marker. This marker is based on the E. coli hygromycin B phosphotransferase gene, which is under the control of the TAKA promoter in pJaL 77 and the amdS promoter in pJaLl54. Briefly, these vectors are constructed as follows. The gene conferring resistance to hygromycin B is purchased from Boehringer Mannheim as plasmid pHph-1.
  • This gene is equipped with an ATG codon as well as with suitable restriction sites at the amino and carboxy termini by PCR, using the primers: 5 ' -GCT CAG AAGCTT CCATCC TAC ACC TCA GCA ATG TCG CCT GAA CTC ACC GCG ACG TCT- 3' (N-terminal) and 3 ' -CGT CCG AGG GCA AAG GAA TAG CTCCAG AGATCT CAT GCT-5 ' (C-terminal) .
  • the PCR fragment is cut with the restriction enzymes BamHI and Xhol and cloned into the corresponding sites in the Aspergillus expression vector PT0C68 (as described in WO 91/17243) to produce pJaL77.
  • the 694 bp PCR fragment containing the amdS promoter is cut with BamHI and SphI and cloned into the corresponding site in pJaL77, so that the TAKA promoter in pJaL77 is exchanged with the amdS promoter.
  • the plasmid pToC90 containing the amdS marker is constructed by cloning a 2.7 kb Xbal fragment from p3SR2 (Hynes et al., supra) into an bal cut and dephosphorylated PUC19 plasmid.
  • the derivative designated pToCl ⁇ is identical to pToC90 except that the promoter region contains two mutations (I 9 and I 666 ) known to enhance expression of the amdS gene (Hynes et al., supra; Corrick et al., Gene 53: 63-71, 1987).
  • the vector pHD414 is a derivative of the plasmid p775 (EP 238 023). In contrast to this plasmid, pHD414 has a string of unique restriction sites between the TAKA promoter and the AMG terminator. The plasmid is constructed by removal of an approximately 200 bp long fragment (containing undesirable RE sites) at the 3' end of the terminator, and subsequent removal of an approximately 250 bp long fragment at the 5' end of the promoter, also containing undesirable sites.
  • the 200 bp region is removed by cleavage with Narl (positioned in the pUC vector) and Xbal (just 3' to the terminator), subsequent filling in the generated ends with Klenow DNA polymerase + dNTP, purification of the vector fragment on a gel and religation of the vector fragment.
  • This plasmid is called pHD413.
  • pHD413 is cut with StuI (positioned in the 5' end of the promoter) and PvuII (in the pUC vector) , fractionated on gel and religated, resulting in pHD414.
  • DSM 6995 coli containing the approximately 1,100 bp xylanase Malawi/Xbal cDNA fragment in pYES is deposited in DSM as DSM 6995.
  • the xylanase cDNA fragment is isolated from one of the clones by cleavage with Hindlll/Xbal. The fragment is purified by agarose gel electrophoresis, electroeluted, and made ready for ligation reactions.
  • the cDNA fragment is ligated into pHD414 to produce pAXX40-l-l
  • SEQ ID NOS 1 and 2 The sequence of the xylanase gene and protein are provided in SEQ ID NOS 1 and 2, and the gene is deposited as DSM (Deutsche Sammlung Von Mikrooroganismen und Zellkulturen GmbH) 6995. .
  • Humicola insolens cellulase Detailed characterization of the Humicola insolens cellulase is found in WO 91/17243.
  • the expression vector pCaHj418 used for cellulase expression is constructed by excision of the 926 bp cellulase coding region fragment from pCaHj201 by cleavage with restriction enzymes BamHI and Sail. This fragment is purified by preparative gel electrophoresis using standard techniques and ligated with pHD414 (described above) which has been prepared by treatment with BamHI and Xhol.
  • the resulting expression vector, pCaHj418, contains the cellulase gene under the transcriptional control of the A .
  • Poly(A) -containing RNA is obtained by two cycles of affinity chromatograp y on oligo (dT) -cellulose as described by Aviv and Leder (PNAS USA 69: 1408-1412, 1972) .
  • cDNA is synthesized with the use of methods described by Okayama and Berg (Molec. Cell. Biol. 2: 161-170, 1982), and with the vectors pSP62-K2 and pCDVl-PL described by Noma et al. (Nature 319: 640-646, 1986) .
  • the synthesized cDNA is transformed into a hsdR-, M+ derivative of E. coli MC1000
  • the filters are hybridized with the 3 2 P -i a belled H. lanuginosa lipase-specific pentadecamer mixture as described by Boel et al. (EMBO J. 3: 1097-1102, 1984). Hybridization and washing of the filters are done at 37'C and 43'C, respectively, followed by autoradiography for 24 hours with an intensifier screen.
  • Miniprep plasmid DNA is isolated from two hybridizing colonies, pHLL 702.3 and pHLL 702.4 by standard procedures (Birnboim and Doly, Nucleic Acids Res. 7: 1513-1523, 1979) and the DNA sequence of the DNA insert is established by the procedure of Maxam and Gilbert (Methods Enzymol. 65: 499-560, 1980) .
  • DNA sequences containing unique restriction sites are added to the 5' and 3' ends of the cDNA as follows. pHLL 702.3 is digested with Sau961 which digests the cDNA in the 3 ' untranslated region and the resulting ends are filled in with E. coli DNA polymerase (Klenow fragment) and the four dNTPs. This DNA is subsequently digested with Sad which cuts the cDNA once just 3 ' to the initiating methionine codon. The resulting 0.9 kb cDNA fragment is purified by agarose gel electrophoresis; electroeluted and made ready for ligation reactions.
  • oligonucleotides 927 and 928 are synthesized.
  • This adaptor is designed to add a Hindl l and BamHI site just 5' to the initiating Met codon of the cDNA.
  • the two oligos are kinased with ATP and T polynucleotide kinase, annealed to each other and ligated to the purified 0.9 kb cDNA sequence in a pUCl9 vector digested with Hindlll and Hindi and purified on a 0.7% agarose gel.
  • the resulting plasmid carries the H. lanuginosa lipase cDNA as a portable 0.9 kb BamHI fragment.
  • p960 is modified by replacing 60 basepairs of the 5 'untranslated region of the A. oryzae TAKA promoter just upstream to the Humicola lanuginosa lipase gene by the corresponding region from the A. nidulans tpiA gene (McKnight et al.
  • a synthetic oligonucleotide containing the 5 ' untranslated region from the A. nidulans tpiA flanked at each end by 20 bases homologous to p960 sequences just outside the untranslated region is used in a PCR reaction together with another primer covering the BssHII-site in the TAKA promoter region, as the mutagenization primer covers the BamHI site close to the ATG start codon, the PCR fragment is digested with BamHI and BSSHII and recloned into p960 digested with BssHll and partially with BamHI. 200 bases upstream to the ATG in • MHan37 is verified by DNA sequencing analysis. The sequence difference between p960 and pMHan37 is shown below:
  • sequence of the primer covering the BamHI site 5 ' GCTCCTCATGGTGGATCCCCAGTTGTGTATATAGACCATTGAGGAAGGAAGA GAAGTGTGGATAGAGGTAAATTGAGTTGGAAACTCCAAGCATGGCATCCCTTGC 3 '
  • Coyrinus cinereu ⁇ peroxidase The isolation and cloning of the Coprinus cinereus peroxidase gene is described in WO 92/16634. Briefly, total RNA is extracted from homogenized Coprinus cinereus (IFO 8371) mycelium, collected at the time of maximum peroxidase activity as described by Boel et al. (EMBO J. 3_: 1097-1102, 1984) and Chirgwin et al . (Biochemistry 18: 5294-5299, 1979) .
  • Poly (A) -containing RNA is obtained by two cycles of affinity chromatography on oligo (dT) -cellulose as described by Aviv and Leder (PNAS USA 69: 1408-1412, 1972) .
  • cDNA is synthesized by means of a cDNA synthesis kit from Invitrogen according to the manufacturer's instructions. About 50,000 E. coli recombinants from the Coprinus cinereus cDNA library are transferred to Whatman 540 paper filters. The colonies are lysed and immobilized as described by Gergen et al. (Nucleic Acids Res. 7: 2115-2135, 1979) .
  • the filters are hybridized with the 3 2 P-labelled 430 base pair peroxidase- specific probe in 0.2 X SSC, 0.1% SDS. Hybridization and washing of the filters is conducted at 65"C followed by autoradiography for 24 hours with an intensifier screen. After autoradiography, the filters are washed at increasing temperatures followed by autoradiography for 24 hours with an intensifier screen. In this way, more than 50 positive clones are identified. Miniprep plasmid DNA is isolated from hybridizing colonies by standard procedures (Birnboim and Doly, Nucleic Acids Res.
  • the DNA sequence of the cDNA insert is determined by the Sanger dideoxy procedure (Sanger et al., PNAS USA 74: 5463-5467, 1977) .
  • the peroxidase cDNA fragment is excised from the vector by cleavage with Hindlll/X ol and is purified by agarose gel electrophoresis, electroeluted and made ready for ligation reactions.
  • the cDNA fragment is ligated to Hindlll/Xhol digested HD414 to generated pCip in which the cDNA is under transcriptional control of the TAKA promoter from A . oryzae and the AMG terminator from A . niger.
  • pJVi9 is prepared from pCiP in that the restriction sites for
  • the cutinase expression vector pCaHj427 contains the Fusarium solani f. pisi cutinase coding region (Soliday et al., J. Bacteriol. 171: 1942-1951, 1989) under the transcriptional control of the A. oryzae T.AKA-amylase promoter and A. niger glucoamylase terminator regions (Christiansen et al., Figure 1, supra) . This is used, with pToC90 as described above, to cotransform A. foetidus strains NRRL 341, NRRL 357, and CBS 103.14.
  • Candida antarctica lipase B contains the Candida antarctica lipase B gene under the control of the A. oryzae TAKA amylase promoter and A. glucoamylase terminator regions (Christiansen et al., supra) . This vector is used with pToC90, as described above, to transform A. foetidus strains CBS103.14, NRRL 356, NRRL 357, and NRRL 341.
  • YPD Garnier et al. Methods in Yeast Genetics, Cold Spring Harbor Laboratory, 1981
  • the mycelium is harvested by filtration through miracloth and washed with 200 ml of 0.6 M MgS0 4 .
  • the suspension is cooled on ice and 1ml of buffer containing 120 mg of Novozyme® 234 is added.
  • Plasmids pToC90 and pToCl86 contain the A . nidulans amdS gene, and are used for transformation and selection for growth on acetamide as the sole nitrogen source. Plasmids pJaL77 and pJaLl54 are used for transformation and selection of resistance to hygromycin B.
  • Cotransformants for lipase activity are cultured in a M400Da medium consisting of 50 g/1 altodextrin, 2g/l MgS0 -7H 2 0, 2g/l KH 2 P0 4 , 3g/l K 2 S0 , 4g/l citric acid, 8g/l yeast extract, 3g/l (NH 4 ) 2 S0 4/ 0.5 ml
  • Lipase activity in culture filtrates is measured using p-nitrophenylbutyrate (pNB) as a substrate.
  • pNB p-nitrophenylbutyrate
  • a stock solution of pNB is prepared by adding 104.6 ⁇ l of pNB to 5 ml of DMSO.
  • To each well of a microtiter plate is added 90 ⁇ l of 50mM Tris, pH 7.
  • Ten ⁇ l of sample is added to each well, and mixed by shaking the microtiter plate for about one minute.
  • 20 ⁇ l of pNB stock is combined with 970 ⁇ l of 50 mM Tris buffer, pH 7 and mixed.
  • the pNB-Tris mixture are added to each sample well and absorbance measured at 405 nm over a 3 minute time period.
  • the assay is temperature sensitive, so an internal standard is used with each sample set.
  • the slope determined for each sample directly correlates to lipase activity; the linear range of the assay is from about 0.005 to 5 ⁇ g lipase per milliliter.
  • the specific activity of H. lanuginosa lipase is determined to be approximately 4000 LU/mg, whereas the specific activity of Candida lipase A is about 400 LU/mg.
  • All xylanase transformants are grown in medium with the following composition, in g/1: maltodextrin, 50; MgSo 4 -7H 2 0,
  • Cellulase transformants are grown in MY50 medium (50 g/1 maltodextrin, 2g/l MgS0 -7H 2 0, lOg/1 KH 2 P0 , 2g/l K 2 S0 , 2g/l citric acid, 10 g/1 yeast extract, 0.5 ml trace metals, 2.0 g urea, at 34 * C as submerged cultures.
  • MY50 medium 50 g/1 maltodextrin, 2g/l MgS0 -7H 2 0, lOg/1 KH 2 P0 , 2g/l K 2 S0 , 2g/l citric acid, 10 g/1 yeast extract, 0.5 ml trace metals, 2.0 g urea, at 34 * C as submerged cultures.
  • Cellulase activity is measured using 0.2% AZCL-HE- cellulose (Megazyme) as a substrate suspended in 0.1M citrate-phosphate buffer at pH 6.5.
  • the culture is diluted in 0.1M citrate buffer, pH 6.5, and 10 ⁇ l of diluted culture fluid is mixed with 1 ml of 0.2% AZCL-HE-cellulose.
  • the mixture is incubated at 42'C for 30 minutes with shaking every 5 minutes. After incubation, the undigested substrate is pelleted by centrifugation at 10,000 rpm for 5 minutes.
  • the blue color in the supernatant is quantified spectrophotometrically at 595 run, and the amount of enzyme activity is determined from a standard curve made with a known cellulase standard.
  • Endocellulase units ECU are determined relative to an enzyme standard prepared under identical conditions.
  • Cotransformants for CiP are cultured in a M400Da medium consisting of 50 g/1 maltodextrin, 2g/l MgS0 4 -7H 2 0, 2g/l KH 2 P0 4 , 3g/l K 2 S0 , 4g/l citric acid, 8g/l yeast extract,
  • Peroxidase expression is monitored using ABTS as a substrate or by rocket immunoelectrophoresis compared to a standard of known concentration.
  • 1% agarose in TM buffer 1.3g/l Tris base, 0.6 g/1 maleic acid, pH 7
  • TM buffer 1.3g/l Tris base, 0.6 g/1 maleic acid, pH 7
  • 400 ⁇ l of rabbit antiserum against CiP is mixed with 15 ml of agarose, spread and solidified on a 10cm x 10 cm plate.
  • E. Cutinase Selected transformants are screened on tributyrin agar(13% maltodextrin, 0.3% MgS0 4 -7H 2 0, 0.5% KH 2 P0 4 , 0.4% citric acid, 0.6% K 2 S0 4 , 0.5% yeast extract, 1% tributyrin, 1% urea, 0.3% NaN0 3 , 0.5ml trace metals, 2% agar, pH 4.5) for the ability to produce extracellular cutinase, as detected by the clearing of tributyrin.
  • the strains producing the largest clearing zones are evaluated in shake flask cultures using M400Da medium(described above) at 37'C.
  • Extracellular cutinase activity is determined using p-nitrophenylbutyrate as described above.
  • the highest cutinase producer is an A. foetidus CBS 103.14 transformant designated CBS 103.14/CaHj427.1. Over the course of three days in shake flask culture, this transformant produces extracellulsar cutinase at leveles that are roughly eequal to the amount produced by an A. oryzae control transformant Qu-1-1. In small scale (2 liters) fermentation, this transformant produces approximately one gram per liter of extracellular cutinase.
  • Table 2 summarizes the expression levels of various heterologous fungal enzymes produced by the alternative host of the present invention. It can be seen from the table that all strains were successful in expression of at least one of the genes of interest. In several cases, the new host strains give unexpectedly high levels of enzyme. For example, at least one strain of A. foetidus yields surprisingly high levels of HLL in shake flask cultures (approximately one gram per liter) , demonstrating that these species are capable of expressing large quantities of heterologous protein. In fact, the levels of production of HLL produced by these transformants appears to be as good as or better than the best primary transformants of A. oryzae, such as HL-23. Similarly, two strains exhibit similar high levels of expression of lipase B.
  • A. foetidus also is shown to be an excellent host for the production of xylanase compared with A. oryzae .
  • the shake flask yields for this enzyme are approximately twice the levels seen for the best A. oryzae transformants.
  • MOLECULE TYPE DNA (genomic)
  • ATC AAC TAC GGC GGC TAC TTC AAC CCC CAG GGC AAC GGC TAC CTG GCC 455 lie Asn Tyr Gly Gly Tyr Phe Asn Pro Gin Gly Asn Gly Tyr Leu Ala 95 100 105 110
  • ATC CGC AAG AAC AAG CGT GTC GGA GGC TCG GTC AAC ATG CAG AAC CAC 695 lie Arg Lys Asn Lys Arg Val Gly Gly Ser Val Asn Met Gin Asn His 175 180 185 190
  • Ala lie Ala Ala Pro Phe Asp Phe Val Pro Arg Asp Asn Ser Thr Ala 20 25 30
  • Gly Ser lie lie Ala His Ser Asn lie Glu Leu Ala Phe Pro Ala Asn 100 105 110

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne un nouveau système d'expression dans lequel des cellules hôtes d'aspergillus foetidus sont utilisées pour exprimer des enzymes hétérologues.
EP95903612A 1993-12-01 1994-11-29 SYSTEME D'EXPRESSION A $i(ASPERGILLUS FOETIDUS) Withdrawn EP0730656A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16059193A 1993-12-01 1993-12-01
US160591 1993-12-01
PCT/US1994/013612 WO1995015390A1 (fr) 1993-12-01 1994-11-29 SYSTEME D'EXPRESSION A $i(ASPERGILLUS FOETIDUS)

Publications (1)

Publication Number Publication Date
EP0730656A1 true EP0730656A1 (fr) 1996-09-11

Family

ID=22577518

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95903612A Withdrawn EP0730656A1 (fr) 1993-12-01 1994-11-29 SYSTEME D'EXPRESSION A $i(ASPERGILLUS FOETIDUS)

Country Status (8)

Country Link
EP (1) EP0730656A1 (fr)
JP (1) JP3113284B2 (fr)
CN (1) CN1139456A (fr)
AU (1) AU690617B2 (fr)
CA (1) CA2178008A1 (fr)
DE (1) DE730656T1 (fr)
FI (1) FI962287A (fr)
WO (1) WO1995015390A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1008738A3 (fr) * 1994-06-17 1996-07-02 Solvay Systeme d'expression, vecteur d'integration et cellule transformee par ce vecteur d'integration.
US5821350A (en) * 1995-11-01 1998-10-13 Nexia Biotechnologies, Inc. Aspergillus niger beta-galactosidase gene
EP1433843A3 (fr) * 1995-12-18 2005-04-13 AB Enzymes Oy Nouvelles xylanases, gènes les codant, et leurs utilisation
US6383781B1 (en) 1998-12-23 2002-05-07 Novozymes A/S Methods for producing polypeptides in aspergillus mutant cells
ES2317706T3 (es) * 1998-12-23 2009-04-16 Novozymes A/S Metodo para produicir polipeptidos en celulas mutantes de aspergillus.
JP4446085B2 (ja) 2001-10-05 2010-04-07 独立行政法人産業技術総合研究所 フェノールオキシダーゼ遺伝子を導入した植物、及び該植物によるフェノールオキシダーゼの生産方法
CN102618449B (zh) * 2012-04-01 2014-05-28 云南省微生物发酵工程研究中心有限公司 一种溶磷菌及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3854249T2 (de) * 1987-08-28 1996-02-29 Novonordisk As Rekombinante Humicola-Lipase und Verfahren zur Herstellung von rekombinanten Humicola-Lipasen.
EP0565172A1 (fr) * 1992-04-10 1993-10-13 Quest International B.V. Clonage et expression d'un ADN codant pour une forme de maturation d'un polypeptide avec activité sulfhydryl oxidase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LUI HD ET AL.: "[Development of a new system for selection of A. foetidus transformed with foreign genes by using thymidine kinase gene as a marker and expression of HBsAg in A. foetidus].", ACTA MICROBIOLOGICA SINICA, vol. 30, no. 2, April 1992 (1992-04-01), BEIJING, CHINA, pages 98 - 104 *

Also Published As

Publication number Publication date
JPH09505481A (ja) 1997-06-03
FI962287A0 (fi) 1996-05-31
WO1995015390A1 (fr) 1995-06-08
AU690617B2 (en) 1998-04-30
DE730656T1 (de) 1998-04-30
CN1139456A (zh) 1997-01-01
CA2178008A1 (fr) 1995-06-08
AU1260995A (en) 1995-06-19
JP3113284B2 (ja) 2000-11-27
FI962287A (fi) 1996-07-26

Similar Documents

Publication Publication Date Title
EP0777737B1 (fr) Systeme d'expression de fusarium non pathogene, non toxicogene, non toxique, et promoteurs et terminateurs utilises dans ce systeme
EP1826271B1 (fr) Système d'expression fongique thermophile
EP0956338B1 (fr) Cellules hotes et procedes de production de proteines
EP1502952A2 (fr) Procédé de production de produits protéiniques dans Aspergillus Oryzae et promoteur à utiliser dans Aspergillus
US5744323A (en) Process for producing heme proteins
US5667990A (en) Aspergillus expression system
US7163804B1 (en) Non-toxic non-toxigenic non-pathogenic fusarium expression system
AU690617B2 (en) (Aspergillus foetidus) expression system
CA2132299A1 (fr) Procede de production des proteines hemiques

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960701

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

TCAT At: translation of patent claims filed
DET De: translation of patent claims
17Q First examination report despatched

Effective date: 19981106

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010102